ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.
| Current Price | ₹101.75 |
|---|---|
| Market Cap | ₹545 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 85.5 |
| Return on Equity | 2.13% |
| 52-Week Range | ₹59.31 – ₹127.00 |
| Beta (1Y) | 0.94 |
| Dividend Yield | 0.00% |
1. Pharmaceuticals-100%
Zim Laboratories Ltd is trading at ₹101.75, with a market capitalisation of ₹545 Cr.
Zim Laboratories Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Medicinal Chemicals and Botanical Products).
Zim Laboratories Ltd has a P/E of 85.5 and a return on equity of 2.13%.